Bioequivalence and Bioavailability Forum

147 matches found.

• NDA and ANDA Bio study NK 2026-03-20 07:18 [Regulatives / Guidelines]
• ICH M12 Drug Inter­action Studies: De­ter­mi­nation of No-Effect Boundaries BEQool 2025-11-26 12:58 [Regulatives / Guidelines]
• Point Estimate consideration in sample size estimate kimhuang 2025-10-09 09:21 [Power / Sample Size]
• And the FDA… Helmut 2024-06-19 13:22 [GxP / QC / QA]
• BioBridges 2023 Helmut 2023-04-06 12:52 [Conferences / Workshops]
• Requesting data for a publication 📥 ♻️ 🚀 Helmut 2023-02-23 11:46 [General Sta­tis­tics]
• Groups, sites… Helmut 2022-12-03 14:09 [BE/BA News]
• ICH M12 (DDI studies) Helmut 2022-07-29 15:53 [BE/BA News]
• Interpreting results of a DDI study Helmut 2022-07-27 11:52 [Design Issues]
• Drug-drug interaction with two different route of admi­nistration Mr.Rao 2022-07-27 10:31 [Design Issues]
• Drug-drug interaction with two different route of administration Mr.Rao 2022-07-22 09:23 [Design Issues]
• Drug-drug interaction with two different route of administration dshah 2022-07-21 20:51 [Design Issues]
• Drug-drug interaction with two different route of administration Mr.Rao 2022-07-21 13:24 [Design Issues]
• Drug-drug interaction with two different route of administration dshah 2022-07-20 12:27 [Design Issues]
• Drug-Drug Interaction procedure -between inhalation and oral Tab Mr.Rao 2022-07-15 10:47 [Regulatives / Guidelines]
• Drug-drug interaction with two different route of administration Mr.Rao 2022-07-14 11:05 [Design Issues]
• Drug-drug interaction with two different route of administration Mr.Rao 2022-07-13 15:51 [Design Issues]
• Hydrophilic Interaction Liquid Chromatography Helmut 2021-11-17 12:43 [Bioanalytics]
• Oh dear! Helmut 2021-10-04 18:10 [NCA / SHAM]
• TSD statistical model - with multiple sites Helmut 2021-07-20 23:52 [Two-Stage / GS Designs]
• Failed study Helmut 2021-04-27 02:33 [Study As­sess­ment]
• WHO frequent deficiencies in protocols and reports Helmut 2020-12-22 20:00 [BE/BA News]
• Interlude II (simulations) Helmut 2020-08-19 23:31 [RSABE / ABEL]
• Subject-by-Formulation interaction? Helmut 2020-07-22 14:03 [Study As­sess­ment]
• Desultory thoughts Helmut 2020-07-15 19:33 [🇷 for BE/BA]
• Fed (IBD) → fasting Helmut 2020-07-01 13:14 [General Sta­tis­tics]
• Pediatric study for a combination product jag009 2020-02-20 20:59 [Regulatives / Guidelines]
• helter-skelter Helmut 2020-02-06 21:12 [RSABE / ABEL]
• zigzag Mikalai 2020-02-06 12:38 [RSABE / ABEL]
• intergender differences and no consequences Helmut 2019-12-04 12:23 [Regulatives / Guidelines]
• EMA example mittyri 2019-11-21 13:38 [Design Issues]
• EEU FDC Scenario 5.3.2 PharmCat 2019-11-20 16:39 [Design Issues]
• EEU-rules, TSD-methods (lengthy answer) Helmut 2019-09-12 03:31 [Two-Stage / GS Designs]
• Group by sequence interaction, an urban myth? Helmut 2019-08-07 16:35 [General Sta­tis­tics]
• Good News only Helmut 2019-07-27 15:15 [Study As­sess­ment]
• Possible reasons for group effect GM 2019-07-23 08:23 [Design Issues]
• Long term stability deepakpangavhane 2019-01-14 13:05 [Bioanalytics]
• Long term stability Ohlbe 2019-01-11 01:00 [Bioanalytics]
• FDA-Subject by formulation interaction (Switchability) jag009 2018-03-28 23:33 [Regulatives / Guidelines]
• IRB reserves Relaxation 2018-01-16 19:18 [Design Issues]